These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 37273452)
1. TMEM33 as a Prognostic Biomarker of Cervical Cancer and Its Correlation with Immune Infiltration. Zhang H; Wang J; Yang J; He Q; Guan S; Qiao M; Zhao J; Wang X Mediators Inflamm; 2023; 2023():5542181. PubMed ID: 37273452 [TBL] [Abstract][Full Text] [Related]
2. High Expression of TMEM33 Predicts Poor Prognosis and Promotes Cell Proliferation in Cervical Cancer. Chen H; Zhao X; Li Y; Zhang S; Wang Y; Wang L; Ma W Front Genet; 2022; 13():908807. PubMed ID: 35832191 [No Abstract] [Full Text] [Related]
3. High Expression of CCDC34 Is Associated with Poor Survival in Cervical Cancer Patients. Liu LB; Huang J; Zhong JP; Ye GL; Xue L; Zhou MH; Huang G; Li SJ Med Sci Monit; 2018 Nov; 24():8383-8390. PubMed ID: 30458457 [TBL] [Abstract][Full Text] [Related]
4. Low Tumor Infiltrating Mast Cell Density Reveals Prognostic Benefit in Cervical Carcinoma. Guo F; Kong WN; Li DW; Zhao G; Wu HL; Anwar M; Shang XQ; Sun QN; Ma CL; Ma XM Technol Cancer Res Treat; 2022; 21():15330338221106530. PubMed ID: 35730194 [No Abstract] [Full Text] [Related]
5. Reduced 2,4-dienoyl-CoA reductase 1 is served as an unfavorable biomarker and is related to immune infiltration in cervical cancer. Guo S; Jiang H; Deng Y; Dong Y; Yin A; Wang Q; Lan Q; Zhang Y; Xu C J Obstet Gynaecol Res; 2023 Oct; 49(10):2475-2486. PubMed ID: 37497824 [TBL] [Abstract][Full Text] [Related]
6. CircRNA-Based Cervical Cancer Prognosis Model, Immunological Validation and Drug Prediction. Guo X; Chen S; Wang S; Zhang H; Yin F; Guo P; Zhang X; Liu X; Han Y Curr Oncol; 2022 Oct; 29(11):7994-8018. PubMed ID: 36354693 [TBL] [Abstract][Full Text] [Related]
7. Construction and validation of a metabolic gene-associated prognostic model for cervical carcinoma and the role on tumor microenvironment and immunity. Huang J; Luo F; Shi M; Luo J; Ma C; Li S; Wei Y; Guo R; Li T Aging (Albany NY); 2021 Dec; 13(23):25072-25088. PubMed ID: 34852326 [TBL] [Abstract][Full Text] [Related]
8. Prognosis Analysis and Validation of Fatty Acid Metabolism-Related lncRNAs and Tumor Immune Microenvironment in Cervical Cancer. Lang X; Huang C; Cui H J Immunol Res; 2022; 2022():4954457. PubMed ID: 35942212 [TBL] [Abstract][Full Text] [Related]
9. GLTP Is a Potential Prognostic Biomarker and Correlates with Immunotherapy Efficacy in Cervical Cancer. Shi YL; Liu MB; Wu HT; Han Y; He X Dis Markers; 2022; 2022():9109365. PubMed ID: 35845139 [TBL] [Abstract][Full Text] [Related]
10. Utility of a metabolic-associated nomogram to predict the recurrence-free survival of stage I cervical cancer. Zhang Y; Lu H; Zhang J; Wang S Future Oncol; 2021 Apr; 17(11):1325-1337. PubMed ID: 33631974 [TBL] [Abstract][Full Text] [Related]
11. PMEPA1 Serves as a Prognostic Biomarker and Correlates with Immune Infiltrates in Cervical Cancer. Li J; Kong WM J Immunol Res; 2022; 2022():4510462. PubMed ID: 35497877 [TBL] [Abstract][Full Text] [Related]
12. Long noncoding RNA PCAT6 regulates cell growth and metastasis via Wnt/β-catenin pathway and is a prognosis marker in cervical cancer. Lv XJ; Tang Q; Tu YQ; Yan DD; Wei QC Eur Rev Med Pharmacol Sci; 2019 Mar; 23(5):1947-1956. PubMed ID: 30915737 [TBL] [Abstract][Full Text] [Related]
13. Comprehensive analysis of lncRNA-mRNA co-expression networks in HPV-driven cervical cancer reveals the pivotal function of LINC00511-PGK1 in tumorigenesis. Xin X; Jia-Yin Y; Jun-Yang H; Rui W; Xiong-Ri K; Long-Rui D; Liu J; Jue-Yu Z Comput Biol Med; 2023 Jun; 159():106943. PubMed ID: 37099974 [TBL] [Abstract][Full Text] [Related]
14. Long noncoding RNA SOX21-AS1 promotes cervical cancer progression by competitively sponging miR-7/VDAC1. Zhang X; Zhao X; Li Y; Zhou Y; Zhang Z J Cell Physiol; 2019 Aug; 234(10):17494-17504. PubMed ID: 30912129 [TBL] [Abstract][Full Text] [Related]
15. The significance of m6A RNA methylation modification in prognosis and tumor microenvironment immune infiltration of cervical cancer. Guo Y; Bai Y; Wang L; Xu Z; Wang X; Wang W Medicine (Baltimore); 2022 Jul; 101(26):e29818. PubMed ID: 35777046 [TBL] [Abstract][Full Text] [Related]
16. Pan-Cancer Analysis of Immune Cell Infiltration Identifies a Prognostic Immune-Cell Characteristic Score (ICCS) in Lung Adenocarcinoma. Zuo S; Wei M; Wang S; Dong J; Wei J Front Immunol; 2020; 11():1218. PubMed ID: 32714316 [No Abstract] [Full Text] [Related]
17. EGR1 promotes stemness and predicts a poor outcome of uterine cervical cancer by inducing SOX9 expression. Zhao J; Li H; Yuan M Genes Genomics; 2021 May; 43(5):459-470. PubMed ID: 33687657 [TBL] [Abstract][Full Text] [Related]
18. Tripartite motif containing 62 is a novel prognostic marker and suppresses tumor metastasis via c-Jun/Slug signaling-mediated epithelial-mesenchymal transition in cervical cancer. Liu TY; Chen J; Shang CL; Shen HW; Huang JM; Liang YC; Wang W; Zhao YH; Liu D; Shu M; Guo LY; Hu Z; Yao SZ J Exp Clin Cancer Res; 2016 Oct; 35(1):170. PubMed ID: 27793172 [TBL] [Abstract][Full Text] [Related]
19. Family with Sequence Similarity 83 Member H Promotes the Viability and Metastasis of Cervical Cancer Cells and Indicates a Poor Prognosis. Chen C; Li HF; Hu YJ; Jiang MJ; Liu QS; Zhou J Yonsei Med J; 2019 Jul; 60(7):611-618. PubMed ID: 31250574 [TBL] [Abstract][Full Text] [Related]
20. MicroRNA-378a-3p Downregulation as a Novel Biomarker with Poor Clinical Outcomes in Cervical Cancer. Zhang L; Wu ZA Biomed Environ Sci; 2021 Mar; 34(3):213-221. PubMed ID: 33766217 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]